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ABSTRACT
PURPOSE: To investigate the effects of intravenous L-arginine (LG) infusion on liver morphology, function and proinflammatory 
response of cytokines during the early phase of ischemia-reperfusion injury (IRI).
METHODS: Thirty rabbits were subjected to 60 minutes of hepatic ischemia and 120 minutes of reperfusion. An intravenous injection 
of saline or L-arginine was administered five minutes before the ischemia and five minutes before initiating the reperfusion and at the 
55th and 115th minutes after the ischemia. Samples were collected for histological analysis of the liver and measurements of the serum 
AST, ALT and LDH and the cytokines IL-6 and TNF-alpha.
RESULTS: It was observed a significant reduction of sinusoidal congestion, cytoplasmic vacuolization, infiltration of polymorphonuclear 
leukocyte, nuclear pyknosis, necrosis and steatosis in liver tissue, as well as AST, ALT and LDH after injection of LG in the ischemia 
(p <0.001). Lower levels of IL-6 and TNF-alpha were associated with LG infusion during ischemia. Higher levels these proteins were 
observed in animals receiving LG during reperfusion.
CONCLUSION: L-arginine protects the liver against ischemia/reperfusion injury, mainly when is administered during the ischemic 
phase.
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RESUMO
OBJETIVO: Investigar os efeitos da infusão endovenosa da L-arginina (LG) na morfologia, função e resposta de citocinas pró-
inflamatórias do fígado durante a fase precoce da lesão de isquemia e reperfusão (IRI).
MÉTODOS: Trinta coelhos foram submetidos a 60 minutos de isquemia hepática e 120 minutos de reperfusão. Foi administrada 
injecção intravenosa de solução salina ou L-arginina aos cinco minutos antes de iniciar a isquemia e cinco minutos antes de iniciar a 
reperfusão e aos 55 e 115 minutos após o início da isquemia. Realizou-se análise histológica do fígado e dosagens séricas de AST, ALT, 
LDH, citocinas IL-6 e TNF-alfa.
RESULTADOS: Ocorreu redução significante da congestão sinusoidal, vacuolização citoplasmática, infiltração de leucócitos 
polimorfonucleares, picnose nuclear, necrose e esteatose no tecido hepático, assim como nos níveis de AST, ALT e LDH após a injeção 
da LG na isquemia (p<0,001). Níveis mais baixos de IL-6 e TNF-alfa foram associados com a infusão LG durante a isquemia. Níveis 
mais elevados dessas proteínas foram observados nos animais que receberam LG durante a reperfusão.
CONCLUSÃO: A L-arginina protegeu o fígado contra a lesão de isquemia e reperfusão principalmente quando administrada durante 
a fase de isquemia.
Descritores: Óxido Nítrico. Arginina. Isquemia Quente. Citocinas. Antioxidantes. Interleucina-6. Fígado. Coelhos.
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Introduction
Ischemia-reperfusion injury (IRI) is associated with 
multiple events that affect liver function following transient 
episodes of hepatic ischemia, such as solid organ transplantation, 
trauma, hypovolemic shock, and elective liver resection, when 
inflow occlusion or total vascular exclusion is used to minimize 
blood loss1. Alterations in the hepatic microcirculation and a 
decrease in hepatic flow can cause local hypoxia and, consequently, 
liver damage. The liver is further compromised following the 
reintroduction of blood flow and oxygen delivery to the damaged 
areas2. 
One of the earliest events associated with the reperfusion 
of an ischemic liver is endothelial dysfunction that is characterized 
by a decreased production of endothelial cell-derived nitric oxide 
(eNO)3. This rapid post-ischemic decrease in NO bioavailability 
appears to be due to a decrease in the synthesis of NO, enhanced 
inactivation of NO via the overproduction of superoxide, or both 
phenomena3,4.
NO availability has been shown to be beneficial in 
various experimental models5-10. Organ infusion with NO donors 
or supplementation with L-arginine (LG), a substrate for NO 
synthases (NOS), minimizes hepatic injury by improving the 
microcirculation11. In animal models of IRI, inhibitors of NOS 
promote tissue injury11. However, high tissue levels of NO may also 
have harmful effects12-16. Collectively, these observations suggest 
a balance between the local NO concentration and the time of NO 
exposure in determining the outcome of liver IRI8. Irrespective 
of the precise mechanisms involved, increased inflammation and 
cytotoxicity are key components in hepatocellular dysfunction 
during the pathogenesis of liver IRI16-20.
The development of new therapeutic approaches to 
control IRI may be aided by a better understanding of the defense 
mechanisms that occur in the liver when it is subjected to ischemic 
insults 21. The LG-NOS pathway has been critically implicated in 
liver IRI, and most studies have suggested that intravenous LG 
infusion increases NO levels and protects the liver against damage 
due to IRI8-20.
The purpose of the present study was to evaluate the effects 
of intravenous LG infusion on liver morphology and function and 
to evaluate the proinflammatory response of cytokines during the 
early phase of IRI in an experimental model using rabbits. 
Methods
The experimental protocol (1815/08) was approved by 
the Ethics Committee of the Federal University of Sao Paulo 
(UNIFESP), Brazil, on according to the recommendations of 
the international legislations on animal protection. The study 
was designed as a randomized controlled trial with a blinded 
assessment of the outcome. 
Thirty male New Zealand white rabbits (Center for the 
Development of Experimental Models for Medicine and Biology 
- CEDEME-UNIFESP) that weighed 2.500 to 3.000g were housed 
under temperature - and light - controlled environmental conditions 
with a 12-hour light-dark cycle. The animals had free access to 
water and standard pellet chow until six hours prior to the surgical 
procedures. All procedures were conducted in the laboratories of 
Experimental Surgery, Department of Surgery (UNIFESP). 
The animals were randomly assigned to one of four 
groups (Figure 1): the ischemia plus saline (I-SS) group (n=6), 
the ischemia and reperfusion plus saline (IR-SS) group (n=6), 
the ischemia plus LG (I-LG) group (n=6), and the ischemia and 
reperfusion plus LG (IR-LG) group (n=6). All animals were 
subjected to 60 minutes of lobar ischemia and 120 minutes 
of reperfusion. In the I-SS and I-LG groups, an intravenous 
administration of saline or LG, respectively, was performed both 
five minutes (T-5) before starting the ischemia and five minutes 
(T55) before starting the reperfusion. In the IR-SS or IR-LG 
groups, saline or L-arginine, respectively, was administered at both 
the 55th (T115) and 115th (T175) minutes during the reperfusion. 
At 120 minutes after starting the reperfusion (T-180), the animals 
were euthanized.
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FIGURE 1 - Schematic distribution of the animals in the groups: 
I-SS (ischemia and saline); IR-SS (ischemia/reperfusion and saline); 
I-LG (ischemia and L-arginine); IR-LG (ischemia/reperfusion and 
L-arginine).  Periods of drugs administration: T-5 (five minutes before 
starting ischemia); T0 (starting ischemia); T55 (five minutes before 
starting reperfusion); T60 (starting reperfusion); T115 (five minutes 
before the first hour of reperfusion); T175 (five minutes before finishing 
reperfusion); T180 (finishing the reperfusion). Gray bars (Ischemia); Blue 
bars (Reperfusion). Green arrow (Saline); Orange arrow (L-arginine). 
White arrow (periods).
Anesthesia and euthanasia procedures
After 6h of fasting for a solid diet and 4h for a liquid diet, 
the animals received a combination of 80 mg/kg of ketamine i.m. 
(Ketalar™, Medical Division of Pfizer do Brazil) and 10 mg/kg of 
xylazine i.m. (Rompum™, Bayer, Sao Paulo, Brazil). Anesthesia 
was maintained connected to a volume-controlled ventilator 
(Harvard ventilator, Harvard Apparatus, USA). The animals 
were ventilated at a rate of 30 breaths/min with a tidal volume 
of 10 mL/kg, an inspired oxygen fraction of 1.0, and a positive 
end-expiratory pressure of 2 cmH2O. The marginal ear artery and 
vein were catheterized, and the systemic arterial pressure, oxygen 
saturation (SpO2), and heart rate were continuously monitored 
(Datex Ohmeda Type F-CU8, Helsinki, Finland). Sodium heparin 
(500 IU/kg) was administered via the peripheral ear vein. Body 
temperature was maintained at 37.8oC using a rabbit homeothermic 
soft blanket (40 x 70 cm) with a YSI 401 rectal temperature probe.
After the samples were collected, the animals received a 
combination of intravenous (0.3 ml/Kg) embutamide, mebezone 
and tetracain (T61™, Schering Plough, Sao Paulo, Brazil), which 
promotes rapid death.
Surgical procedure
Under aseptic conditions, all 30 animals underwent a 
midline laparotomy. The hepatic hilum was carefully dissected 
with identification of the hepatic artery, portal vein, and bile duct. 
The left and median hepatic lobes were occluded with a small 
vascular clamp. Ischemia was confirmed by observing the pale 
appearance of the clamped liver lobes. The appearance of the 
intestines and signs of portal compression were also observed. 
A SpO2 after the clamp was removed, reperfusion was evaluated 
based on immediate color recovery. In cases in which an absence 
of ischemic color or a lack of response to the reperfusion was 
observed, the animals were excluded from further analyses. The 
surgical wounds remained covered with wet gauze wrappings 
throughout the experiment to minimize evaporative loss. Sham 
animals underwent anesthesia, laparotomy, and exposure of the 
portal triad without hepatic ischemia.
Serum assays
Blood samples were collected after 120 minutes of 
reperfusion. The samples were centrifuged, and the serum was 
separated. Hepatic damage was evaluated (units per liter) based 
on the serum levels of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), and lactate dehydrogenase (LDH), which 
were measured using an in vitro diagnostic chemistry reagent kit 
(Catachem Inc., Bridgeport, Conn).
Histological processing
Liver samples were immersed in 10% buffered formalin. 
After 24 hours, the samples were embedded in paraffin, cut 
into 5-μm sections and stained with hematoxylin and eosin. All 
histological analyses were performed by a single pathologist who 
was blinded to the treatment of the groups. We used a computerized 
image analysis system consisting of a Nikon™ FDX – 35 video 
camera coupled to a Nikon optic microscope (Eclipse 800, Tokyo, 
Japan) with multicolor objectives that transmitted images to a 
Pentium MMX MHz Vaio PC (Sony, Tokyo, Japan) equipped with 
a digitizing board and Image Pro-Plus™ software (Version 4.5) 
(Media Cybernetics, Inc., Bethesda, MD, USA). 
Sinusoidal congestion, cytoplasmic vacuolation, 
infiltrating polymorphonuclear leukocytes (PMNLs), nuclear 
pyknosis, hepatocyte necrosis and steatosis were all assessed 
using a colorimetric scale (red, green and blue). Each parameter 
was marked individually and expressed as a percentage of the total 
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area of each slide.
Real-time PCR for TNF-alpha and IL-6
Frozen liver tissues were stored liquid nitrogen to 
evaluate the gene expression of TNF-alpha (F:5′-GCTCCTC 
ACTCACACTGTCAG-3′ and R:5′-GCAATGATCCCAAAG 
TAGAC-3′), IL-6 (F:5′-GCTGAGGAAAGAGATGTGTGAC-3′ 
and R:5′ GTCTTGATCAGGTGTTGGATGT-3′), and the 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (F:5′-GATTTGGCCGCATTGG-3′ and R:5′-
ACATCCACTTTGCCAGAGTTAA-3′).
Total RNA was prepared from the frozen liver tissues 
using the TRIzol/chloroform extraction method (Invitrogen, 
Paisley, UK), reverse transcribed into cDNA using an iScript 
cDNA Synthesis Kit, and subjected to quantitative real-time PCR 
(RT-PCR) using Platinum SYBR Green qPCR SuperMix-UDG 
(Invitrogen Inc., NY, USA) and the primers listed above with an 
iCycler (Bio-Rad) instrument and the associated software. All of 
the PCR oligonucleotide primer pairs were designed using Bio-
Rad Beacon Designer 2.0 software and purchased from Invitrogen. 
The ΔΔCT values were calculated by subtracting
 the CT values for 
the gene of interest from those obtained for GAPDH and then 
subtracting the CT value for each
 gene from those determined for 
the non-operated control rabbits. The fold induction was calculated 
by normalizing the values to those obtained for the control rabbits.
Total RNA was treated with DNase (Invitrogen Inc., NY, 
USA), and separated by gel electrophoresis. Reverse-transcribed 
cDNA was then subjected to real time PCR analysis using the ABI 
PRISM 7000 Sequence Detection System (Applied Biosystems, 
CA, USA). The reaction mixtures had a final volume of 20 μL and 
contained 1 μL of cDNA (per sample) and 9 μL of 2X Platinum 
SYBR Green qPCR SuperMix-UDG (Invitrogen Inc., NY, USA) 
(40 mM Tris-HCl (pH 8.4), 100 mM KCl, 6 mM MgCl2, 400 µM 
dATP, 400 µM dCTP, 400 µM dGTP, 800 µM dUTP, 40 units/
mL UDG, 60 units/mL Platinum Taq DNA Polymerase, and 
stabilizers)22-24. The gene fragments were amplified by 30 cycles 
of PCR, with each consisting of 15 s at 94 C, 30 s at 55°C, and 
1 min at 72°C. 
Statistical analysis
Parametric results are expressed as the mean ± standard 
deviation, and the Shapiro-Wilks test was performed to check the 
normality of the data prior to statistical evaluation. ANOVA (one-
way or two-way factorial variance for comparisons of ischemia 
versus reperfusion) and Tukey’s post-hoc test were used to identify 
the two-way variance in the same group (SPSS ver. 18.0, SPSS 
Inc., Chicago, IL, USA). A p<0.05 was considered significant.
Results 
Histological analysis
Histological analysis of the liver revealed multiple, 
extensive areas of hepatocyte necrosis that were randomly 
distributed throughout the parenchyma in the IR-SS group (Figure 
2, top). The results were similar in the I-SS group (Figure 2 top), 
but the areas of necrosis were slightly less frequent. Furthermore, 
sinusoidal congestion and cytoplasmic vacuolation were randomly 
disseminated in the latter group. In the I-LG and IR-LG groups 
(Figure 2, bottom), the morphological structure of the liver was 
preserved, and an absence of columnar disorder of the hepatocytes 
was observed. In the IR-LG group, however, cytoplasmic 
vacuolation and PMNL infiltration were frequently observed. 
The greatest reductions in areas (µm2) of sinusoidal congestion, 
cytoplasmic vacuolation, infiltrating PMNLs, nuclear pyknosis, 
hepatocyte necrosis, and steatosis were observed in the I-LG 
group followed sequentially by the IR-LG group, the I-SS group 
and the IR-SS group (Table 1). 
FIGURE 2 - Histological damage in the I-SS and IR-SS groups (top). 
Extensive area of hepatic necrosis, severe disarrangement of the hepatic 
columnar cells, cytoplasmic vacuoles (white arrows), PMNL infiltration 
(blue arrows), vascular congestion (orange arrows) and nuclear pyknosis 
(yellow arrows). Histological damage in the I-LG and IR-LG groups 
(bottom). Rare hepatic necrosis, preservation of the hepatic columnar 
cells, rare cytoplasmatic vaculoes (white arrows), minimal PMNL 
inflitration (blue arrows), an absence of vascular congestion and puctuate 
nuclerar pyknosis (yellow arrows). Hematoxylin and eosin (magnification 
200x).
Taha MO et al.
620 - Acta Cirúrgica Brasileira - Vol. 27 (9) 2012
TABLE 1 - Percentage of areas (µm2) of hepatic damage 
determined by colorimetric method in the saline groups (Ischemia 
and Ischemia /Reperfusion) and L-arginine group (Ischemia and 
Ischemia /Reperfusion).
I-SS IR-SS I-LG IR-LG
Sinusoidal Congestion 39±03 52±05 13±03 21±03
Infiltrating PMNL 23±02 48±05 17±01 26±02
Cytoplasmatic 
Vacuolation 30±07 52±04 12±02 23±03
Nuclear Picnosis 27±06 43±05 13±04 16±03
Hepatocyte  Necrosis 47±06 62±05 14±04 18±05
Steatosis 31±05 41±07 21±05 25±06
ANOVA test (Tukey test post –hoc) (p<0.001) - For all parameters: I-LG< 
IR-LG<I-SS <IR-SS
Biochemical assessment
Consistent with the morphological analysis, the 
biochemical assessment of liver cytolysis showed that LG 
administration during the ischemic phase reduced the serum levels 
of AST, ALT and LDH (Figure 3). This reduction was significantly 
greater when LG was administered during the ischemic phase 
compared to during the reperfusion phase (p<0.001). 
FIGURE 3 - The means±sd values (U/L) of aspartate aminotransferase 
(AST), in I-SS (194 ± 4), IR-SS (1110 ± 93), I-LG (92 ± 11) and IR-
LG (758 ± 21); alanine aminotranferase (ALT) in I-SS (858 ± 41), IR-SS 
(1227 ± 82), I-LG (511 ± 26) and IR-LG (691 ± 54); lactate dehydrogenase 
(LDH) in I-SS (858 ± 41), IR-SS (1227 ± 82), I-LG (511 ± 26) and IR-LG 
(691 ± 54). ANOVA followed by Tukey Test (p<0.05).
Cytokine expression
The highest level of TNF-alpha expression was detected 
in the IR-SS group, and a significantly lower level of expression 
was measured in the I-SS group (p=0.001) (Figure 4). LG infusion 
during the ischemic phase resulted in the lowest level of TNF-
alpha expression and demonstrated a value that was significantly 
lower than that detected in the group that received LG during the 
reperfusion phase (p<0.05).
The highest expression levels of the proinflammatory 
cytokine IL-6 were also observed in the IR-SS group followed 
by the I-SS group (p<0.001) (Figure 4). LG infusion during the 
ischemic phase resulted in the lowest expression level of IL-6 
and demonstrated a value that was significantly lower than that 
detected in the group that received LG during the reperfusion 
phase (p<0.001). 
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FIGURE 4 - TNF-alpha/GAPDH expression in the I-SS (3.69±0.362), 
IR-SS (5.10±0.497), I-LG (1.356±0.443) and IR-LG (2.075±0.416); IL6/
GAPDH expression in the I-SS group (2.21±0.14), IR-SS (4.76±0.372), 
I-LG (1.6±0.052) and IR-LG (2.73±0.121). ANOVA followed by Tukey 
Test (p<0.05).
Discussion
The present results showed that intravenous LG infusion 
during the pre-ischemic and ischemic phases promoted greater 
protection against IRI damage in hepatocytes compared to LG 
infusion during the reperfusion phase. We demonstrated the 
protective effects of intravenous LG on the parenchymal integrity 
of the liver, reduced serum levels of enzymes associated with liver 
cytolysis, and inhibition of the expression of the proinflammatory 
cytokines TNF-alpha and IL-6.
The experimental IRI model used herein was reliable 
with respect to the promotion of parenchymal and functional liver 
damage. IRI was established by clamping the vessels to the left 
lateral and median hepatic lobes, which account for 70% of the 
rabbit liver mass25. In other animal models, it has been reported 
that hepatic insult is similar to the clinical situation in which the 
liver is rendered ischemic during total vascular exclusion for liver 
resection25-28. Indeed, in the present study, 60 minutes of hepatic 
warm ischemia followed by 120 minutes of reperfusion caused 
severe liver injury in rabbits, as demonstrated by the structural 
damage to the liver and the increased serum levels of AST, ALT, 
and LDH. In addition, liver IRI increased the expression levels of 
the proinflammatory cytokines TNF-alpha and IL-6. 
IRI has been shown to occur during an early phase of 
reperfusion that begins following reoxygenation and during a 
delayed phase. The early phase is associated with hepatocellular 
damage during the period from 2 to 6h after reperfusion 
(reoxygenation), whereas the delayed phase occurs from 18 
to 24h after reperfusion and is accompanied by a massive 
infiltration of PMNLs4,25. Liver IRI is known to be associated with 
microcirculatory flow disturbances, endothelial cell adhesion, and 
leukocyte tethering and infiltration. Local leukocyte infiltration 
depends on both extravasation across the vascular endothelium and 
migration through the extracellular matrix8. Leukocytes play an 
important role at the interface of the portal blood flow and exposure 
to pathogenic and nonpathogenic antigens. Moreover, they are an 
important component involved in liver IRI and function both to 
amplify the molecular pathways associated with IRI and to cause 
cellular damage directly8. After two hours of reperfusion, our IRI 
model displayed areas of severe necrosis and PMNL infiltration. 
Together with the above-mentioned changes, the serum 
levels of LDH, ALT, and LDH were significantly increased in 
rabbits that were exposed to hepatic IRI, which indicated that 
cellular injury had been induced in the liver. PMNL-independent 
injury is thought to be initiated by changes in the redox state of the 
liver that produce a more oxidative environment within the cells4. 
IRI is associated with a remarkable decrease in the 
bioavailability of NO, which represents an important initiating 
event in the pathophysiology of post-ischemic injury in a variety 
of different tissues, including the liver, heart, kidney, and gut4. 
Several pharmacological agents have been used to 
attenuate IRI in the liver. These agents may directly inhibit the 
progression of the lesion, or they may induce a low level of 
stress in the liver cells, which in turn initiates a cellular defense 
mechanism against more aggressive insults during the late phase11.
NO is a gaseous free radical that exerts protective effects 
during IRI. It is produced by NOS enzymes that use LG and oxygen 
as substrates to generate L-citrulline and NO. NO is an important 
messenger molecule in a variety of physiological systems and 
serves many physiological purposes, such as the promotion of 
vasodilatation and the mediation of communication between 
cells in the nervous system1. In addition to its physiological 
effects, excessive levels of NO may cause cellular damage via a 
phenomenon known as nitrosative stress7. Thus, the role of NO 
in IRI is controversial. NO has been reported to have beneficial 
effects in attenuating organ damage due to IRI, but it may also 
exert harmful effects8,9. NO production via iNOS in macrophages 
is known to cause oxidative damage by interacting with the 
superoxide anion produced by the enzymatic complex NADPH 
oxidase. This process leads to the production of peroxynitrite, 
which is a potent oxidant and induces cell death10. Peroxynitrite has 
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dual effects; it can be harmful8, or it can promote hepatoprotection 
via a decrease in leukocyte adhesion and infiltration13. Our results 
suggest that the delivery of NO is protective, depending on the 
phase during which it enters the cascade of events in liver IRI. 
Intravenous LG injection during early stages of ischemia showed a 
stronger protective effect than that observed during the late phase 
of reperfusion. 
Hepatoprotection via the LG-NOS pathway has been 
previously established in animal models of IRI18,19. Given that 
the LG-NOS pathway has been reported to play critical roles 
during inflammation, our data support the hypothesis that the 
administration of LG during the ischemic phase is beneficial by 
attenuating liver injury in a model of warm hepatic IRI.
The transcription factor NF-κB plays a major role in 
inflammation and in survival signaling pathways. It participates 
in both protective mechanisms and in generating the inflammatory 
cytokines TNF-alpha and IL-6, the balance of which ultimately 
controls the fate of the liver during IRI29. The activation of 
inflammatory cytokines is mediated by reactive oxygen species 
and is associated with the induction of protective genes that 
are essential for the maintenance of liver functions29. Cytokines 
are key mediators within the complex interplay of intrahepatic 
immune cells and hepatocytes because they can activate the 
effector functions of immune cells and the intracellular hepatocyte 
signaling pathways that control cellular homeostasis. Kupffer cells 
and liver-infiltrating monocyte-derived macrophages are primary 
sources of cytokines such as TNF-alpha and IL-630. Although we 
did not specifically investigate the activity of Kupffer cells, our 
results revealed a direct relationship between the morphological 
and functional impairment of hepatocytes and the levels of TNF-
alpha and IL-6. L-arginine infusion significantly decreased the 
expression of TNF-alpha and IL-6, which suggested a protective 
effect of LG against liver IRI during the early stage of reperfusion 
until 120 minutes after reperfusion.
Liver IRI comprises a number of complex processes that 
involve multiple cellular and molecular pathways. However, NO 
depletion during the early stage of reperfusion is associated with 
a biochemical cascade of events that results in an impairment of 
liver function. The administration of an exogenous NOS substrate 
via intravenous LG injection was effective in protecting the liver 
against IRI. 
Conclusion
L-arginine protects the liver against ischemia/reperfusion 
injury, mainly when is administered during the ischemic phase.
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